FK506 IN PEDIATRIC KIDNEY TRANSPLANTATION - PRIMARY AND RESCUE EXPERIENCE

Between December 14, 1989, and December 17, 1993,43 patients undergoing kidney transplantation alone at the Children’s Hospital of Pittsburgh received FK506 as the primary immunosuppressive agent. The mean recipient age was 10.2 ± 4.8 years (range 0.7–17.4), with 7 (16%) children under 5 years of ag...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Shapiro, Ron, Scantlebury, Velma P., Jordan, Mark L., Vivas, Carlos, Tzakis, Andreas G., Ellis, Demetrius, Gilboa, Nisan, Hopp, Laszlo, McCauley, Jerry, Irish, William, Mitchell, Sandi, Hakala, Thomas R., Simmons, Richard L., Starzl, Thomas E.
Format: Artigo
Jezik:Inglês
Izdano: 1995
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2966300/
https://ncbi.nlm.nih.gov/pubmed/7492486
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items